Cutting-edge science in medicinal chemistry
The Marie Skłodowska-Curie Actions (MSCA) Doctoral Network MC4DD follows an interdisciplinary and cross-sectoral approach to expand the opportunities of macrocycles as next-generation drug modalities. It brings together 8 academic and 5 industrial groups who are experts in macrocyclic drug discovery with their competences covering the fields of organic synthesis, medicinal, high-throughput and computational chemistry, pharmacological and structural analytics, and modelling. It is coordinated by the Technische Universität Darmstadt, Germany, and offers a mobility and training platform for young scientists by means of cross-site, interdisciplinary research projects. |
Join our vibrant research community
Our project offers excellent research and training in medicinal chemistry and drug discovery. We promote the careers of young researchers by offering intersectoral and multidisciplinary mobility and training in a variety of aspects in medicinal chemistry. To complement the academic and scientific goals, we offer customized research projects, structured interdisciplinary, local and network-wide transferable skills training activities, and secondments at top-ranking European universities and industry partners. |
Our 17 Ph.D. positions have now been filled!
MC 4DD Offers to its Doctoral Candidates (DCs):
• International PhD program and environment
• Interdisciplinary double supervision
• Sturctured Doctoral Training via dedicated thematic workshops
• Extracurricular seminars and workshops
• Researcher Mobility via Secondments to our network partners
• Academic and industrial experience
MC 4DD Offers to its Doctoral Candidates (DCs):
• International PhD program and environment
• Interdisciplinary double supervision
• Sturctured Doctoral Training via dedicated thematic workshops
• Extracurricular seminars and workshops
• Researcher Mobility via Secondments to our network partners
• Academic and industrial experience

This project has received funding from the European Union´s HORIZON-MSCA-2023-DN-01 under Grant Agreement 101168916.